Healthcare - Biotechnology - NASDAQ - US
$ 2.66
-3.97 %
$ 220 M
Market Cap
-1.05
P/E
CASH FLOW STATEMENT
-132 M
OPERATING CASH FLOW
-3.73 M
INVESTING CASH FLOW
118 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Editas Medicine, Inc.
| Net Income | -153 M |
| Depreciation & Amortization | 6.06 M |
| Capital Expenditures | -4.72 M |
| Stock-Based Compensation | 19.8 M |
| Change in Working Capital | -1.59 M |
| Others | 1.71 M |
| Free Cash Flow | -137 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (153.2) | (220.4) | (192.5) | (116.0) | (133.7) | (110.0) | (120.3) | (97.2) | (72.9) | (13.7) | (5.3) |
| Depreciation & Amortization | 6.1 | 6.3 | 5.1 | 4.0 | 2.8 | 3.3 | 2.7 | 1.2 | 0.5 | 0.2 | 3 K |
| Deferred Income Tax | 0 | 0 | 0 | (16.4) | 0 | (3.7) | 0 | 87 K | 84 K | 2 K | 0 |
| Stock Based Compensation | 19.8 | 29.3 | 43.4 | 23.2 | 27.2 | 26.6 | 23.4 | 16.9 | 3.5 | 55 K | 60 K |
| Other Operating Activities | (3.2) | (0.7) | 1.7 | 27.6 | (2.9) | 11.2 | 14.2 | 10.6 | 0.3 | 0.7 | 1.3 |
| Change in Working Capital | (1.6) | 8.2 | (21.4) | (102.2) | 65.9 | 26.9 | 70.7 | 18.5 | 63.1 | 4.1 | 1.2 |
| Cash From Operations | (132.2) | (177.3) | (163.8) | (179.8) | (40.7) | (45.7) | (9.4) | (49.9) | (5.4) | (8.7) | (2.8) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (4.7) | (4.1) | (8.0) | (7.2) | (6.2) | (4.8) | (2.1) | (3.5) | (1.4) | (1.2) | (0.2) |
| Other Items | 1.0 | 118.2 | (46.5) | (133.4) | 18.4 | (48.3) | (181.8) | (1.6) | 0 | 0 | 0 |
| Cash From Investing Activities | (3.7) | 114.1 | (54.5) | (140.5) | 12.3 | (53.1) | (183.8) | (5.1) | (1.4) | (1.2) | (0.2) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | (0.9) | (0.8) | (0.6) | (0.5) | 18.4 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.0 | 1.3 | 32.6 | 20.4 | 15.5 | 11.0 | 155.3 | 0.2 | 281.6 | 0 | 9.0 |
| Cash From Financing Activities | 118.0 | 1.3 | 282.1 | 224.1 | 131.8 | 86.9 | 154.5 | 97.2 | 139.4 | 18.5 | 9.0 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (17.9) | (62.0) | 63.8 | (96.2) | 103.4 | (11.9) | (38.7) | 42.1 | 132.6 | 8.6 | 6.0 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (136.9) | (181.5) | (171.8) | (187.0) | (46.8) | (50.5) | (11.5) | (53.4) | (6.8) | (9.9) | (2.9) |